openPR Logo
Press release

Rubella Testing Market - Positive long-term growth outlook 2016 - 2024

01-02-2018 12:47 PM CET | Health & Medicine

Press release from: Transparency Market Research

/ PR Agency: Transparency Market Research
Rubella Testing Market - Positive long-term growth outlook 2016

Rubella or German measles is a serious condition (disease) caused by the infection of rubivirus (genus). Sometimes rubella when passed from pregnant mother to her baby then it is termed as congenital rubella. Rubella is a contagious disease and can spread through air or close contact between patient and a healthy individual. Signs and symptom of rubella include fever, headache, inflammation of the eyes and muscle or joint pain. Culture test (nasal or throat swab culture) and blood test to check the function of immune system are the major tests performed for the detection of rubella. Women who are pregnant must undergo rubella test to know the functioning of immune system against rubella virus. There remains chance of miscarriage or stillbirth for those pregnant mothers who are suffering from measles as the child may be born with birth defects.

Browse Premium Industry Research Report with Analysis: https://www.transparencymarketresearch.com/rubella-diagnostic-testing-market.html

Presently there is no treatment option available in the market for the treatment of rubella. Patients are prescribed acetaminophen for reduction of rubella fever. Rubella can be prevented with the utilization of measles-mumps-rubella (MMR) vaccine. Rubella vaccine is recommended for all children and is routinely given when children are 12 months to 15 months old. Almost everyone who receives the vaccine has immunity to rubella for his lifetime. The global market for rubella testing is being driven primarily due to increasing awareness among people and advancement in diagnostic test. Moreover, government initiatives and support also accounted for the growth of the global rubella testing market. Pregnant mother who are suffering from rubella and are unaware about the high risk of passing the disease from her to unborn baby also contributes significantly in the market growth.

Request for Brochure of Report: https://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=2935

Centre for Disease Control and Prevention (CDC) stated that more than 100,000 infants are born with congenital rubella syndrome (CRS) annually worldwide. World Health Organization (WHO) revealed that in 1996, the number of countries that have incorporated rubella-containing vaccines into their routine national immunization program was 83. Later in 2011, the number was increased to 130 for the incorporation of rubella-containing vaccines into their routine national immunization. North America dominates the global market for rubella testing due to strong demand of diagnostic test in this region. Moreover increasing awareness among people and initiative taken by the federal government also accounted for the market growth in North American region. Europe represents the second position in the global rubella testing market due to increasing awareness among people and extensive government initiative taken by the European government. For an instance, in October 2010, WHO Region of the America and Europe has established rubella elimination and CRS prevention goals for the year 2010 and 2015.

Asia – Pacific is considered as an untapped market due to lack of awareness among people about rubella testing. Asian market growth will be fuelled by the presence of untapped opportunities due to extensive increase in the healthcare infrastructure and growing market penetration in this region. Major market players contributing in the global market share of rubella testing market includes Abbott Laboratories, Inc., Becton, Dickinson and Company, Biomerica, Inc., bioMerieux, Inc., Novartis Diagnostics, Johnson & Johnson Diagnostics, Inc., Olympus Corporation, Qiagen N.V., Siemens AG, Thermo Fischer Scientific, Inc., and Zenith Healthcare Ltd.

Pre Book this Report: https://www.transparencymarketresearch.com/checkout.php?rep_id=2935<ype=S

About Us

Transparency Market Research (TMR) is a market intelligence company, providing global business information reports and services. Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insight for thousands of decision makers. TMR’s experienced team of analysts, researchers, and consultants, use proprietary data sources and various tools and techniques to gather, and analyze information. Our business offerings represent the latest and the most reliable information indispensable for businesses to sustain a competitive edge.

Contact us:

Transparency Market Research
90 State Street,
Suite 700,
Albany
NY - 12207
United States
Tel: +1-518-618-1030
USA - Canada Toll Free 866-552-3453
Email: sales@transparencymarketresearch.com
Website: http://www.transparencymarketresearch.com/

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Rubella Testing Market - Positive long-term growth outlook 2016 - 2024 here

News-ID: 881738 • Views: 108

More Releases from Transparency Market Research

Impact of Outbreak of COVID-19 on Medical Education Market : Global Industry Ana …
Transparency Market Research (TMR) has published a new report on the medical education market for the period of 2019–2027. According to the report, the global medical education market was valued at nearly US$ 31 Bn in 2018, and is projected to expand at a CAGR of more than 4% from 2019 to 2027. Rise in the number of medical schools and increase in cost of medical education are the
Healthcare BI Platform Market Companies Analysis, Advancement and Precise Outloo …
In an intensely competitive healthcare business intelligence (BI) platform market, large players are aggressively focused on expanding their geographical outreach, says Transparency Market Research (TMR) in a new market intelligence report. These large players are leveraging the cloud business model to provide healthcare BI solutions that can be accessed irrespective of location. Apart from this, savvy players are entering into partnerships with hospital groups and healthcare bodies to integrate healthcare BI
Substance Abuse Treatment Market News Research Report 2024
A recent report by Transparency Market Research on the substance abuse treatment market in the U.S. states that the competitive landscape is highly fragmented. This is because around 242 companies compete against one another in it. This also makes overall competition stiff. Some of the companies that have beat competition to emerge as leading players in the market are Pfizer Inc., Alkermes Plc, GlaxoSmithKline Plc., and Purdue Pharma LP. Their
Clinical Oncology Next Generation Sequencing Market is Thriving Worldwide By Siz …
Clinical Oncology Next Generation Sequencing: Introduction Next generation sequencing for tumor and germline DNA is required for oncology screening for therapeutic application. Rise in burden of cancer increases the need for early detection of the condition to carry out the generate target therapy. Companies are investing to develop technologically advanced devices/solutions for precision detection. In 2012, Oxford Nanopore had launched the GridION sequencing platform, which can sequence a human genome in 15

All 5 Releases


More Releases for Rubella

Measles Mumps And Rubella Vaccines Market Global Industry Analysis, size, share …
Measles, Mumps and Rubella (MMR) vaccines are a combination of live viruses which are administered in the form of injections. The live viruses are in an inactivated form and are unable to replicate in the human cells while the immune system produces a response and protects against the infection. The vaccine of MMR has a long term effect. Measles, Mumps and Rubella (MMR) causes cough, fever, rash, headache and severe
Measles, Mumps and Rubella (MMR) Vaccines Market-By Product Type, End Users and …
Measles, mumps, and rubella are the three common contagious airborne diseases that are highly caused by virus transmitted by sneezing and coughing of the infected person, which could lead to serious complications or death among children. Vaccines of these diseases are sold as attenuated viral vaccines, manufactured in a lyophilised formulation, which requires reconstitution with water for injection diluent and are available in two forms i.e. monovalent as well as
Rubella Testing Market to Observe Strong Development by 2024
Rubella or German measles is a serious condition (disease) caused by the infection of rubivirus (genus). Sometimes rubella when passed from pregnant mother to her baby then it is termed as congenital rubella. Rubella is a contagious disease and can spread through air or close contact between patient and a healthy individual. Signs and symptom of rubella include fever, headache, inflammation of the eyes and muscle or joint pain. Culture test
Rubella Testing Market by application, Scope, Analysis and Forecasts to 2024
Rubella Testing Market: Overview Rubella or German measles is a serious condition (disease) caused by the infection of rubivirus (genus). Sometimes rubella when passed from pregnant mother to her baby then it is termed as congenital rubella. Rubella is a contagious disease and can spread through air or close contact between patient and a healthy individual. Signs and symptom of rubella include fever, headache, inflammation of the eyes and muscle
Global ALL Vaccine Market 2017 - Vaccinia , Measles, mumps, rubella , Varicella …
The Worldwide ALL Vaccine Report does an extensive study of the Market Segment, Product categories, market revenue, product cost, Forecast 2017-2022. After that, the Global ALL Vaccine market 2017 Report is segregated into different categories based on geographical regions, key vendors and range of applications. The report also studies the ALL Vaccine Market Share and Growth. The latest ALL Vaccine global report presents insightful details related to the current scenario of
Rubella Testing Market Global Industry Research 2024
Rubella Testing Market: Overview  Rubella or German measles is a serious condition (disease) caused by the infection of rubivirus (genus). Sometimes rubella when passed from pregnant mother to her baby then it is termed as congenital rubella. Rubella is a contagious disease and can spread through air or close contact between patient and a healthy individual. Signs and symptom of rubella include fever, headache, inflammation of the eyes and muscle or